Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print February 7, 2002, doi: 10.1161/01.RES.0000012445.68979.9D
A more recent version of this article appeared on March 22, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/539    most recent
01.RES.0000012445.68979.9Dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by González-Santiago, L.
Right arrow Articles by Rodríguez-Puyol, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by González-Santiago, L.
Right arrow Articles by Rodríguez-Puyol, D.
Related Collections
Right arrow Cell biology/structural biology
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide

Submitted on August 13, 2001
Revised on January 25, 2002
Accepted on January 25, 2002

Decreased Nitric Oxide Synthesis in Human Endothelial Cells Cultured on Type I Collagen

L. González-Santiago ; S. López-Ongil ; M. Rodríguez-Puyol ; and D. Rodríguez-Puyol *

From the Department of Physiology, School of Medicine (L.G.-S., S.L.-O., M.R.-P.), and Nephrology Section (D.R.-P.), Hospital Príncipe de Asturias, Alcalá University, and IRSIN, Madrid, Spain.

* To whom correspondence should be addressed. E-mail: drodriguez{at}hupa.insalud.es.

Endothelial dysfunction, considered as a defective vascular dilatation after certain stimuli, is characteristic of different pathological conditions, such as hypertension, atherosclerosis, or diabetes. A decreased synthesis or an increased degradation of nitric oxide (NO) has been postulated as the mechanism responsible for this alteration. The present experiments were designed to test the hypothesis that the presence of an abnormal extracellular matrix in vessel walls could be responsible for the decreased NO synthesis observed in these pathological conditions. Experiments were performed in cultured human umbilical vein endothelial cells (HUVECs) grown on type IV (Col. IV) or type I (Col. I) collagen. Cells seeded on Col. I showed decreased nitrite synthesis, nitric oxide synthase activity, eNOS protein content, and eNOS mRNA expression when compared with cells grown on Col. IV. Moreover, cells grown on Col. I failed to respond to glucose oxidase activation of the eNOS system. In both cases, the changes in the eNOS mRNA expression seemed to depend on the modulation of eNOS promoter activity. The downregulation of eNOS induced by Col. I was blocked by D6Y, a peptide that interferes with the Col. I--dependent signals through integrins, as well as by specific anti-integrin antibodies. Moreover, a decreased activation of integrin-linked kinase (ILK) may explain the effects observed in Col. I--cultured cells because the activity of this kinase was decreased in these cells and ILK modulation prevented the Col. I--induced changes in HUVECs. Taken together, these findings may contribute to explaining the basis of endothelial dysfunction in some vascular diseases.


Key words: endothelial dysfunction • nitric oxide • extracellular matrix • integrins • integrin-linked kinase




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. S. Packer
Soluble guanylate cyclase (sGC) down-regulation by abnormal extracellular matrix proteins as a novel mechanism in vascular dysfunction: Implications in metabolic syndrome
Cardiovasc Res, February 1, 2006; 69(2): 302 - 303.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. L. Diez-Marques, M. P. Ruiz-Torres, M. Griera, S. Lopez-Ongil, M. Saura, D. Rodriguez-Puyol, and M. Rodriguez-Puyol
Arg-Gly-Asp (RGD)-containing peptides increase soluble guanylate cyclase in contractile cells
Cardiovasc Res, February 1, 2006; 69(2): 359 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. De Frutos, M. Saura, M. Griera, F. J. Rivero-Vilches, C. Zaragoza, D. Rodriguez-Puyol, and M. Rodriguez-Puyol
Differential Regulation of Soluble Guanylyl Cyclase Expression and Signaling by Collagens: Involvement of Integrin-Linked Kinase
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2626 - 2635.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. J. Rivero-Vilches, S De Frutos, M Saura, D Rodriguez-Puyol, and M Rodriguez-Puyol
Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I{alpha} activation by NO/cGMP
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C891 - C898.
[Abstract] [Full Text] [PDF]